Technological watch

Engineering of a decellularized bovine skin coated with antibiotics?loaded electrospun fibers with synergistic antibacterial activity for the treatment of infectious wounds

A decellularized bovine skin (DBS) was fabricated using the decellularization and freeze?drying technique. Polyvinyl alcohol/chitosan?loaded antibiotics?colistin and meropenem (PVA/CS?Ab) were then electrospun on the DBS. The fabricated two?layered construct exhibited excellent biological and biomechanical properties for wound dressing and now promises to proceed with pre?clinical and clinical investigations.An ideal antibacterial wound dressing with strong antibacterial behavior versus highly drug?resistant bacteria and great wound?healing capacity is still being developed. There is a clinical requirement to progress the current clinical cares that fail to fully restore the skin structure due to post?wound infections. Here, we aim to introduce a novel two?layer wound dressing using decellularized bovine skin (DBS) tissue and antibacterial nanofibers to design a bioactive scaffold with bio?mimicking the native extracellular matrix of both dermis and epidermis. For this purpose, polyvinyl alcohol (PVA)/chitosan (CS) solution was loaded with antibiotics (colistin and meropenem) and electrospun on the surface of the DBS scaffold to fabricate a two?layer antibacterial wound dressing (DBS?PVA/CS/Abs). In detail, the characterization of the fabricated scaffold was conducted using biomechanical, biological, and antibacterial assays. Based on the results, the fabricated scaffold revealed a homogenous three?dimensional microstructure with a connected pore network, a high porosity and swelling ratio, and favorable mechanical properties. In addition, according to the cell culture result, our fabricated two?layer scaffold surface had a good interaction with fibroblast cells and provided an excellent substrate for cell proliferation and attachment. The antibacterial assay revealed a strong antibacterial activity of DBS?PVA/CS/Abs against both standard strain and multidrug?resistant clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia coli. Our bilayer antibacterial wound dressing is strongly suggested as an admirable wound dressing for the management of infectious skin injuries and now promises to advance with preclinical and clinical research.

Publication date: 17/01/2024



This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 870292.